We are live on ! Find out more
EIKN

Eikon Therapeutics
EIKN

52 hedge funds and large institutions have $251M invested in Eikon Therapeutics in 2026 Q1 according to their latest regulatory filings, with 52 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

47.06% more ownership

Funds ownership: 0% → 47.06% (+47%)

Holders
52
Holders Change
+52
Holders Change %
–
% of All Funds
0.64%
Holding in Top 10
5
Holding in Top 10 Change
+5
Holding in Top 10 Change %
% of All Funds
0.06%
New
52
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$51.3M
2
BlackRock
BlackRock
New York
+$44.4M
3
FCMI
Foresite Capital Management IV
California
+$26M
4
MC
Merck & Co
New Jersey
+$22.3M
5
FCMV
Foresite Capital Management V
California
+$17.6M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
VFT
26
Vanguard Fiduciary Trust
Pennsylvania
$1.4M +$1.76M +131,954 New
Charles Schwab
27
Charles Schwab
California
$1.39M +$1.75M +131,079 New
Goldman Sachs
28
Goldman Sachs
New York
$1.37M +$1.73M +129,306 New
CFM
29
Comprehensive Financial Management
California
$1.23M +$1.55M +116,276 New
BGM
30
Burkehill Global Management
New York
$1.22M +$1.54M +115,000 New
LP
31
LMR Partners
United Kingdom
$1.22M +$1.54M +115,000 New
UBS Group
32
UBS Group
Switzerland
$1.05M +$1.33M +99,408 New
Bank of America
33
Bank of America
North Carolina
$911K +$1.15M +86,134 New
SGM
34
Seven Grand Managers
New York
$846K +$1.07M +80,000 New
GCM
35
Ghisallo Capital Management
Massachusetts
$741K +$936K +70,000 New
TD Asset Management
36
TD Asset Management
Ontario, Canada
$604K +$763K +57,074 New
Northern Trust
37
Northern Trust
Illinois
$482K +$609K +45,531 New
State Street
38
State Street
Massachusetts
$425K +$537K +40,150 New
Squarepoint
39
Squarepoint
New York
$328K +$414K +30,978 New
Manulife (Manufacturers Life Insurance)
40
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$303K +$383K +28,623 New
XT
41
XTX Topco
Cayman Islands
$276K +$348K +26,056 New
AC
42
AXQ Capital
New Jersey
$163K +$206K +15,408 New
Morgan Stanley
43
Morgan Stanley
New York
$162K +$204K +15,273 New
Tudor Investment Corp
44
Tudor Investment Corp
Connecticut
$159K +$200K +15,000 New
VGA
45
Vanguard Global Advisers
Pennsylvania
$145K +$184K +13,747 New
VPM
46
Vanguard Portfolio Management
Pennsylvania
$144K +$182K +13,613 New
Hudson Bay Capital Management
47
Hudson Bay Capital Management
Connecticut
$143K +$180K +13,480 New
LCM
48
Landscape Capital Management
New Jersey
$110K +$139K +10,381 New
JP Morgan Chase
49
JP Morgan Chase
New York
$12.6K +$17.4K +1,300 New
TRCT
50
Tower Research Capital (TRC)
New York
$12.1K +$15.2K +1,139 New
1
2
3

EIKN Hedge Fund Activity: Q1 2026 in Review

52 of the 8,152 institutional investors tracked by Wall St. Rank reported a position in Eikon Therapeutics (EIKN) for Q1 2026, worth a combined $251M.

Buyers outnumbered sellers: 52 funds opened new EIKN positions and 0 closed out — a net gain of 52 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Fidelity Investments, opening a new position worth an estimated $51.3M.

  • 52 institutional investors held Eikon Therapeutics (EIKN) as of Q1 2026, up from 0 in Q4 2025.
  • Funds reported $251M of Eikon Therapeutics stock for Q1 2026.
  • 52 funds opened new Eikon Therapeutics positions in Q1 2026 and 0 closed out, a net change of +52 holders.
  • The largest Eikon Therapeutics buyer in Q1 2026 was Fidelity Investments, an estimated $51.3M added.

Based on aggregated 13F filings for Q1 2026.